PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $526 | -25.5% | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $706 | +14.2% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $618 | -27.0% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $846 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -80.0% | 200 | -60.8% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 510 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | 0.0% | 510 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | 0.0% | 510 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | 0.0% | 510 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +150.0% | 510 | +155.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -62.5% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | +300.0% | 200 | +100.0% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | -28.6% | 100 | -13.8% | 0.00% | – |
| Q2 2018 | $7,000 | -61.1% | 116 | -57.7% | 0.00% | – |
| Q1 2018 | $18,000 | +80.0% | 274 | +174.0% | 0.00% | – |
| Q4 2017 | $10,000 | -77.3% | 100 | -73.1% | 0.00% | – |
| Q3 2017 | $44,000 | +2100.0% | 372 | +431.4% | 0.00% | – |
| Q4 2016 | $2,000 | -71.4% | 70 | +22.8% | 0.00% | – |
| Q2 2015 | $7,000 | -93.8% | 57 | -88.2% | 0.00% | – |
| Q1 2015 | $113,000 | +21.5% | 482 | -1.6% | 0.00% | – |
| Q4 2014 | $93,000 | +5.7% | 490 | +32.1% | 0.00% | – |
| Q3 2014 | $88,000 | +2100.0% | 371 | +550.9% | 0.00% | – |
| Q2 2014 | $4,000 | -94.7% | 57 | -92.2% | 0.00% | – |
| Q1 2014 | $76,000 | +261.9% | 727 | +263.5% | 0.00% | – |
| Q4 2013 | $21,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |